What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
The scientist’s investigation covers issues in Internal medicine, Myocardial infarction, Cardiology, Surgery and Coronary artery disease.
His study in Angioplasty, Angina, Troponin T, Troponin and Infarction are all subfields of Internal medicine.
Myocardial infarction is frequently linked to Tissue plasminogen activator in his study.
In most of his Cardiology studies, his work intersects topics such as Survival rate.
His Surgery research incorporates themes from Hazard ratio and Confidence interval.
He has researched Coronary artery disease in several fields, including Epidemiology and Heart failure.
His most cited work include:
- Third universal definition of myocardial infarction (5502 citations)
- Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. (4200 citations)
- An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. (3240 citations)
What are the main themes of his work throughout his whole career to date?
Maarten L. Simoons spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Surgery and Coronary artery disease.
Heart failure, Unstable angina, Acute coronary syndrome, Angina and Electrocardiography are among the areas of Internal medicine where the researcher is concentrating his efforts.
His study on Angioplasty, ST segment and Ejection fraction is often connected to In patient as part of broader study in Cardiology.
His work in Infarction, Thrombolysis, Streptokinase, Percutaneous coronary intervention and Eptifibatide is related to Myocardial infarction.
Maarten L. Simoons frequently studies issues relating to Clinical trial and Surgery.
His Coronary artery disease research focuses on subjects like Perindopril, which are linked to ACE inhibitor.
He most often published in these fields:
- Internal medicine (71.64%)
- Cardiology (62.47%)
- Myocardial infarction (47.55%)
What were the highlights of his more recent work (between 2008-2020)?
- Internal medicine (71.64%)
- Cardiology (62.47%)
- Myocardial infarction (47.55%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Heart failure.
His Surgery research extends to the thematically linked field of Internal medicine.
His Cardiology research is multidisciplinary, incorporating perspectives in Randomized controlled trial and Blood pressure.
His research on Myocardial infarction focuses in particular on Percutaneous coronary intervention.
His research in Percutaneous coronary intervention intersects with topics in Conventional PCI and Left bundle branch block.
His Heart failure study integrates concerns from other disciplines, such as Stroke, Revascularization, Heart disease, Microcirculation and Angina.
Between 2008 and 2020, his most popular works were:
- Third universal definition of myocardial infarction (5502 citations)
- 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (3099 citations)
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves (844 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
Maarten L. Simoons focuses on Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Heart failure.
Maarten L. Simoons performs multidisciplinary study on Internal medicine and In patient in his works.
His research integrates issues of Mean arterial pressure and Hazard ratio in his study of Cardiology.
The various areas that Maarten L. Simoons examines in his Myocardial infarction study include Mortality rate, Medical emergency and Intensive care medicine.
Maarten L. Simoons combines subjects such as Placebo, Perindopril and Unstable angina with his study of Coronary artery disease.
The concepts of his Heart failure study are interwoven with issues in Heart disease, Pathophysiology and Sudden cardiac death.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
